Karyopharm Therapeutics | Capitale Sociale E Riserve

Equity Capital And Reserves Cambiamento Data
Amgen USD 6.23B 1.42B 2023-12
AstraZeneca USD 37.2B 195M 2023-09
Avrobio USD 102.86M 19.18M 2023-09
GlaxoSmithKline GBP 13.13B 442M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Roche Holding CHF 26.52B 1.48B 2023-06
Takeda JPY 7.07T 149.3B 2023-09
TG Therapeutics USD 160.5M 4.27M 2023-12
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Xencor USD 668.8M 214K 2023-12



Karyopharm Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.